{"id":6813,"date":"2024-03-06T23:38:11","date_gmt":"2024-03-06T23:38:11","guid":{"rendered":"https:\/\/economicherald.net\/?p=6813"},"modified":"2024-03-06T23:38:11","modified_gmt":"2024-03-06T23:38:11","slug":"top-10-at-11-which-biotech-receives-ethics-approval-for-a-phase-3-trial","status":"publish","type":"post","link":"https:\/\/economicherald.net\/?p=6813","title":{"rendered":"Top 10 at 11: Which biotech receives ethics approval for a Phase 3 trial?"},"content":{"rendered":"

Stockhead\u2019s\u00a0Top 10 at 11, published each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.<\/p>\n

It\u2019s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.<\/p>\n

The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading.<\/p>\n

The\u00a0S&P\/ASX200\u00a0is\u00a0up\u00a0today, gaining\u00a010.60\u00a0points or\u00a00.14%\u00a0to\u00a07,744.10 at 10.30am (AEDT).<\/p>\n

\u00a0<\/p>\n

WINNERS<\/h2>\n

Stocks highlighted in yellow have made market-moving announcements\u00a0(click\u00a0headings to sort).<\/strong><\/em><\/p>\n

<\/div>\n
\n
<\/div>\n

Code Description Last % Volume MktCap CNJ Conico Ltd 0.003 50% 517,500 $3,140,190 M4M Macro Metals Limited 0.006 50% 22,335,306 $11,248,311 ADG Adelong Gold Limited 0.004 33% 1,372,904 $2,153,967 AVE Avecho Biotech Ltd 0.004 33% 3,414,634 $9,507,891 LSR Lodestar Minerals 0.002 33% 5,000,000 $3,035,096 HVY Heavy Minerals 0.105 30% 160,273 $4,667,509 ICE Icetana Limited 0.035 25% 143,882 $7,409,596 EDE Eden Inv Ltd 0.0025 25% 232,732 $7,356,542 CVR Cavalier Resources 0.115 21% 27,776 $3,023,747 VAL Valor Resources Ltd 0.003 20% 166,666 $11,472,533 <\/p>\n

<\/div>\n<\/div>\n

WordPress Table Plugin<\/a><\/p>\n

\u00a0<\/p>\n

Avecho (ASX:AVE)<\/strong><\/a> has announced that Phase 3 clinical trial testing of its oral CBD TPM-enhanced soft-gel capsule for insomnia has gained final ethics approval.<\/a><\/p>\n

AVE says patient recruitment for the pivotal trial is on track to start this month for clinical trial sites in Melbourne, Sydney, Central Coast, Brisbane, and Perth.<\/p>\n

Heavy Minerals (ASX:HVY)<\/strong><\/a> has inked a non-binding Memorandum of Understanding (MOU) for the future sales of a minimum of 15,000 tpa of garnet to be produced at its Port Gregory Project in Western Australia for an initial three-year period with ABSS.<\/p>\n

HVY says the offtake will account for ~10% of the company\u2019s annual future Garnet production at its Port Gregory Project and will be sold into the Australian and New Zealand sand blasting and water jet cutting markets by ABSS.<\/p>\n

\u00a0<\/p>\n

LOSERS<\/h2>\n

Stocks highlighted in yellow have made market-moving announcements\u00a0(click headings to sort).<\/strong><\/em><\/p>\n

<\/div>\n
\n
<\/div>\n

Code Company Price % Volume Market Cap AXP AXP Energy Ltd 0.001 -50% 3,789,544 $11,649,361 VPR Volt Power Group 0.001 -50% 343,790 $21,432,416 SIH Sihayo Gold Limited 0.001 -33% 3,334 $18,306,384 1MC Morella Corporation 0.003 -25% 416,129 $24,715,198 RIE Riedel Resources Ltd 0.003 -25% 31,731 $8,895,343 EPX EPT Global Limited 0.02 -20% 4,500 $14,693,606 AUK Aumake Limited 0.003 -14% 15,224 $6,700,424 POS Poseidon Nick Ltd 0.007 -13% 285,244 $29,708,278 KNI Kuniko Ltd 0.21 -11% 11,000 $20,314,403 CZN Corazon Ltd 0.009 -10% 10,750 $6,155,979 <\/p>\n

<\/div>\n<\/div>\n

WordPress Table Plugin<\/a>
\n<\/span><\/p>\n

The post Top 10 at 11: Which biotech receives ethics approval for a Phase 3 trial?<\/a> appeared first on Stockhead<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"

Stockhead\u2019s\u00a0Top 10 at 11, published each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It\u2019s a short, [more…]<\/a><\/p>\n","protected":false},"author":0,"featured_media":6814,"comment_status":"","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-6813","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance"],"yoast_head":"\nTop 10 at 11: Which biotech receives ethics approval for a Phase 3 trial? - Economic Herald<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/economicherald.net\/?p=6813\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Top 10 at 11: Which biotech receives ethics approval for a Phase 3 trial? - Economic Herald\" \/>\n<meta property=\"og:description\" content=\"Stockhead\u2019s\u00a0Top 10 at 11, published each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It\u2019s a short, [more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/economicherald.net\/?p=6813\" \/>\n<meta property=\"og:site_name\" content=\"Economic Herald\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-06T23:38:11+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6813#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6813\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Top 10 at 11: Which biotech receives ethics approval for a Phase 3 trial?\",\"datePublished\":\"2024-03-06T23:38:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6813\"},\"wordCount\":362,\"publisher\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6813#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/10-3-txOoFl.jpeg\",\"articleSection\":[\"Finance\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6813\",\"url\":\"https:\\\/\\\/economicherald.net\\\/?p=6813\",\"name\":\"Top 10 at 11: Which biotech receives ethics approval for a Phase 3 trial? - Economic Herald\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6813#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6813#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/10-3-txOoFl.jpeg\",\"datePublished\":\"2024-03-06T23:38:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6813#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/economicherald.net\\\/?p=6813\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6813#primaryimage\",\"url\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/10-3-txOoFl.jpeg\",\"contentUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/10-3-txOoFl.jpeg\",\"width\":2067,\"height\":1163},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6813#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/economicherald.net\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Top 10 at 11: Which biotech receives ethics approval for a Phase 3 trial?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#website\",\"url\":\"https:\\\/\\\/economicherald.net\\\/\",\"name\":\"Economic Herald\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/economicherald.net\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\",\"name\":\"Economic Herald\",\"url\":\"https:\\\/\\\/economicherald.net\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/cropped-cropped-economicheraldlogo-1.png\",\"contentUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/cropped-cropped-economicheraldlogo-1.png\",\"width\":850,\"height\":760,\"caption\":\"Economic Herald\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Top 10 at 11: Which biotech receives ethics approval for a Phase 3 trial? - Economic Herald","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/economicherald.net\/?p=6813","og_locale":"en_US","og_type":"article","og_title":"Top 10 at 11: Which biotech receives ethics approval for a Phase 3 trial? - Economic Herald","og_description":"Stockhead\u2019s\u00a0Top 10 at 11, published each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It\u2019s a short, [more...]","og_url":"https:\/\/economicherald.net\/?p=6813","og_site_name":"Economic Herald","article_published_time":"2024-03-06T23:38:11+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/economicherald.net\/?p=6813#article","isPartOf":{"@id":"https:\/\/economicherald.net\/?p=6813"},"author":{"name":"","@id":""},"headline":"Top 10 at 11: Which biotech receives ethics approval for a Phase 3 trial?","datePublished":"2024-03-06T23:38:11+00:00","mainEntityOfPage":{"@id":"https:\/\/economicherald.net\/?p=6813"},"wordCount":362,"publisher":{"@id":"https:\/\/economicherald.net\/#organization"},"image":{"@id":"https:\/\/economicherald.net\/?p=6813#primaryimage"},"thumbnailUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/03\/10-3-txOoFl.jpeg","articleSection":["Finance"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/economicherald.net\/?p=6813","url":"https:\/\/economicherald.net\/?p=6813","name":"Top 10 at 11: Which biotech receives ethics approval for a Phase 3 trial? - Economic Herald","isPartOf":{"@id":"https:\/\/economicherald.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/economicherald.net\/?p=6813#primaryimage"},"image":{"@id":"https:\/\/economicherald.net\/?p=6813#primaryimage"},"thumbnailUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/03\/10-3-txOoFl.jpeg","datePublished":"2024-03-06T23:38:11+00:00","breadcrumb":{"@id":"https:\/\/economicherald.net\/?p=6813#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/economicherald.net\/?p=6813"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/economicherald.net\/?p=6813#primaryimage","url":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/03\/10-3-txOoFl.jpeg","contentUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/03\/10-3-txOoFl.jpeg","width":2067,"height":1163},{"@type":"BreadcrumbList","@id":"https:\/\/economicherald.net\/?p=6813#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/economicherald.net\/"},{"@type":"ListItem","position":2,"name":"Top 10 at 11: Which biotech receives ethics approval for a Phase 3 trial?"}]},{"@type":"WebSite","@id":"https:\/\/economicherald.net\/#website","url":"https:\/\/economicherald.net\/","name":"Economic Herald","description":"","publisher":{"@id":"https:\/\/economicherald.net\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/economicherald.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/economicherald.net\/#organization","name":"Economic Herald","url":"https:\/\/economicherald.net\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/economicherald.net\/#\/schema\/logo\/image\/","url":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/cropped-cropped-economicheraldlogo-1.png","contentUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/cropped-cropped-economicheraldlogo-1.png","width":850,"height":760,"caption":"Economic Herald"},"image":{"@id":"https:\/\/economicherald.net\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts\/6813","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6813"}],"version-history":[{"count":0,"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts\/6813\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/media\/6814"}],"wp:attachment":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6813"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6813"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6813"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}